Page last updated: 2024-11-08

5,6-dehydronorketamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5,6-dehydronorketamine: metabolite of ketamine; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162835
CHEMBL ID3544558
CHEBI ID192730
SCHEMBL ID9131610
MeSH IDM0103669

Synonyms (20)

Synonym
5,6-dehydronorketamine
57683-62-2
CHEBI:192730
dehydronorketamine
6-amino-6-(2-chlorophenyl)cyclohex-2-en-1-one
unii-j5442fvv58
j5442fvv58 ,
2-cyclohexen-1-one, 6-amino-6-(2-chlorophenyl)-
dhnk
dehydro norketamine
6-amino-6-(2-chlorophenyl)-2-cyclohexen-1-one
6-amino-6-(2-chlorophenyl)-2-cyclohexene-1-one
SCHEMBL9131610
CHEMBL3544558
AKOS030240033
Q20164375
1-amino-2'-chloro-5,6-dihydro[1,1'-biphenyl]-2(1h)-one
DTXSID80973283
dehydro norketamine (1.0 mg/ml in acetonitrile)
GLXC-25262

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The elimination half-life values of the parent drug for both biological fluids were similar (4."( Pharmacokinetics and distribution of ketamine after extradural administration to dogs.
Calvo, MB; Dominguez-Gil, A; Gascon, AR; Hernandez, R; Muriel, C; Pedraz, JL; Torres, LM, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]